Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 73 publications
Toward a Pluralistic Model for the Schizophrenia Spectrum-Dopamine and Beyond.
Journal: JAMA psychiatry
Published: July 08, 2026
Xanomeline-Trospium for the Treatment of Schizophrenia.
Journal: Focus (American Psychiatric Publishing)
Published: January 30, 2026
Population Pharmacokinetic-Based Strategies for Switching Patients with Schizophrenia Between Long-Acting Injectable Formulations of Risperidone: R064766 or RBP-7000 to TV-46000.
Journal: Neurology and therapy
Published: June 25, 2025
Feasibility and structure of a state hospital botulinum neurotoxin clinic for clozapine-induced sialorrhea.
Journal: Annals of general psychiatry
Published: May 13, 2025
Clozapine Monitoring in the Post-REMS World: Some Guidance for Clinicians.
Journal: The Journal of clinical psychiatry
Published: May 08, 2025
Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part I: A Review of the Pharmacokinetic Literature and Proposed Changes.
Journal: Journal of clinical psychopharmacology
Published: April 08, 2025
Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part II: A Review of Fatal Outcomes in US Pharmacovigilance Data and Proposed Changes.
Journal: Journal of clinical psychopharmacology
Published: April 08, 2025
Switching Patients with Schizophrenia from Intramuscular Paliperidone Palmitate Once Monthly to TV-46000, a Long-Acting Subcutaneous Antipsychotic: Population Pharmacokinetic-Based Strategies.
Journal: Advances in therapy
Published: March 18, 2025
The efficacy of lithium in the treatment of suicidal ideation, behavior and suicide: An updated systematic review and meta-analysis of randomized controlled trials.
Journal: Journal of affective disorders
Published: March 17, 2025
ENaC inhibitors for the management of lithium related polyuria: a systematic review.
Journal: Journal of affective disorders
Published: January 26, 2025
From theory to therapy: unlocking the potential of muscarinic receptor activation in schizophrenia with the dual M1/M4 muscarinic receptor agonist xanomeline and trospium chloride and insights from clinical trials.
Journal: The international journal of neuropsychopharmacology
Published: December 11, 2024
How antipsychotics work in schizophrenia: a primer on mechanisms.
Journal: CNS spectrums
Published: December 02, 2024
Last Updated: 09/26/2026